Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics Revenue

In the year 2024, Lyra Therapeutics had annual revenue of $1.53M, down -1.54%. Lyra Therapeutics had revenue of $209.00K in the quarter ending December 31, 2024, with 43.15% growth.

• Revenue (ttm): $1.53M
• Revenue Growth: -1.54%
• P/S Ratio: 5.90
• Revenue / Employee: $51,133
• Employees: 30
• Market Cap: 8.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.53M	-24.00K	-1.54%
Dec 31, 2023	1.56M	195.00K	14.31%
Dec 31, 2022	1.36M	1.08M	378.25%
Dec 31, 2021	285.00K	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.